Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Circulation. Cardiovascular Quality and Outcomes|September 1, 2017
Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United StatesEric A Secemsky, Ajay Kirtane, Sripal Bangalore, et al.
JMIR AI|August 27, 2024
Traditional Machine Learning, Deep Learning, and BERT (Large Language Model) Approaches for Predicting Hospitalizations From Nurse Triage Notes: Comparative Evaluation of Resource ManagementDhavalkumar Patel, Prem Timsina, Larisa Gorenstein, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 24, 2023
Effects of Volatile Anesthetics versus Ketamine on Blood-Brain Barrier Permeability via Lipid-Mediated Alterations of Endothelial Cell MembranesBehnam Noorani, Ekram Ahmed Chowdhury, Faleh Alqahtani, et al.
Pharmaceutical Research|October 13, 2023
Discovery of the Next Generation of Non-peptidomimetic Neurolysin Activators with High Blood-Brain Barrier Permeability: a Pharmacokinetics Study in Healthy and Stroke AnimalsYong Zhang, Sejal Sharma, Shirisha Jonnalagadda, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 6, 2010
Akt pathway is hypoactivated by synergistic actions of diabetes mellitus and hypercholesterolemia resulting in advanced coronary artery diseaseDamir Hamamdzic, Robert S Fenning, Dhavalkumar Patel, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 6, 2023
Endothelial-Specific Targeting of RhoA Signaling via CD31 Antibody-Conjugated NanoparticlesBehnaz Lahooti, Racheal G Akwii, Dhavalkumar Patel, et al.
Journal of Leukocyte Biology|August 13, 2013
G protein-coupled receptor kinase-3-deficient mice exhibit WHIM syndrome features and attenuated inflammatory responsesTeresa K Tarrant, Matthew J Billard, Roman G Timoshchenko, et al.
ACS Pharmacology & Translational Science|March 14, 2024
Characterization of a Nonselective Opioid Receptor Functional Antagonist: Implications for Development as a Novel Opioid Dependence MedicationSiavash Shahbazi Nia, Yuma T Ortiz, Julio D Zuarth Gonzalez, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 27, 2026
Discovery of a pyridine-piperazine-based small molecule that enhances the activity of peptidase neurolysinHeba ElSayed ElZorkany, Haya Kandil, Srinidhi Jayaraman, et al.
European Journal of Medicinal Chemistry|April 13, 2023
Studies on diketopiperazine and dipeptide analogs as opioid receptor ligandsSiavash Shahbazi Nia, Mohammad Anwar Hossain, Guangchen Ji, et al.
Pageof 6